Niamh Madigan | 02/12/2013
Looking to comprehensive strategies for structuring and funding innovation driven in non-clinical co-operations through the experiences of the Structural Genomics Consortium (SGC) at University of Oxford. Dr Wen Hwa Lee, the Strategic Alliances Manager talks to Pharma IQ on benefitting from pre-competitive research and shares insight in a compound discovery case study and the journey involved to bring this into the public domain.
Have Your Say
Rate...
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
DigIT Pharma & Health 2024
September 10 - 12, 2024
Düsseldorf, Germany
Register Now |
View Agenda |
Learn More
Temperature Control and Logistics North America Summit
September 10 - 12, 2024
Falls Church, VA
Register Now |
View Agenda |
Learn More